<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>1 Stock That Should Be in Every Investor's Portfolio</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>1 Stock That Should Be in Every Investor's Portfolio</h1>
  <ul>
<li>Q2 revenue gained 38% year over year to $15.56 billion.</li>
<li>alone, revenue increased 37% to $3.3 billion.</li>
<li>In fiscal 2023 and 2024, revenue increased 19.5% and 32% respectively.</li>
<li>Total worldwide sales increased 12% in the second quarter to $1.49 billion.</li>
<li>Looking forward, guidance is calling for 2025 earnings per share of $20.85 to $22.10.</li>
<li>The primary area of growth for this drug was outside the U.S., where revenue grew 19% to $560.3 million year over year.</li>
<li>Between fiscal 2023 and 2024, net income nearly doubled to $10.6 billion.</li>
</ul>
<p><a href="https://finance.yahoo.com/m/8fba6c14-66f5-3eb9-b5e8-8bf7429e2d86/1-stock-that-should-be-in.html">Source</a> · 2025-09-15T10:15:00+00:00</p>
</body>
</html>